FEATURED COMPANIES
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Nemaura Medical Inc.
- RISE Life Science Corp.
- MORE
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Non-Invasive Glucose Monitoring Devices Market: About this market
The non-invasive glucose monitoring devices market analysis considers sales from products such as wearable devices and non-wearable devices. Our analysis also considers the sales of non-invasive glucose monitoring devices in Asia, Europe, North America, and ROW. In 2018, the wearable devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of diabetes, technological advancements, and new product launches will play a significant role in the wearable devices segment to maintain its market position. Also, our global non-invasive glucose monitoring devices market report looks at factors such as increasing prevalence of diabetes and growing number of government programs, product launches and increasing demand for non-invasive procedures. However, product withdrawal from the market due to accuracy issues, high costs associated with non-invasive glucose monitoring devices, and intense competition and strong presence of conventional blood glucometer may hamper the growth of the non-invasive glucose monitoring devices industry over the forecast period.
Global Non-Invasive Glucose Monitoring Devices Market: Overview
Increasing demand for non-invasive procedures
The demand for non-invasive monitoring and diagnostic procedures is increasing owing to their ease of operation, fewer side effects and minimum discomfort. Non-invasive glucose monitoring devices are increasingly being used as alternatives to conventional blood glucose monitoring devices as the latter method causes pain and discomfort to patients. Moreover, it provides real-time data that shows trends in glucose measurements and help in maintaining a standard glucose level by controlling diabetes and complications associated with it. This will lead to the expansion of the global non-invasive glucose monitoring devices market at a CAGR of over 11% during the forecast period.
Integration of AI and RADAR technology in glucose monitoring
The integration of AI and RADAR systems in diagnostic devices has revolutionized the medical industry. This has led the researcher to develop non-invasive glucose monitoring devices combining AI and RADAR technologies, which enables people with diabetes to monitor their blood glucose levels. Vendors are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Such technologies will eliminate the need for finger pricking. The integration of data received from digital medical devices with mobile applications allow customers to easily monitor body parameters, such as changes in glucose levels. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global non-invasive glucose monitoring devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices manufacturers, that include Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.
Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The non-invasive glucose monitoring devices market analysis considers sales from products such as wearable devices and non-wearable devices. Our analysis also considers the sales of non-invasive glucose monitoring devices in Asia, Europe, North America, and ROW. In 2018, the wearable devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of diabetes, technological advancements, and new product launches will play a significant role in the wearable devices segment to maintain its market position. Also, our global non-invasive glucose monitoring devices market report looks at factors such as increasing prevalence of diabetes and growing number of government programs, product launches and increasing demand for non-invasive procedures. However, product withdrawal from the market due to accuracy issues, high costs associated with non-invasive glucose monitoring devices, and intense competition and strong presence of conventional blood glucometer may hamper the growth of the non-invasive glucose monitoring devices industry over the forecast period.
Global Non-Invasive Glucose Monitoring Devices Market: Overview
Increasing demand for non-invasive procedures
The demand for non-invasive monitoring and diagnostic procedures is increasing owing to their ease of operation, fewer side effects and minimum discomfort. Non-invasive glucose monitoring devices are increasingly being used as alternatives to conventional blood glucose monitoring devices as the latter method causes pain and discomfort to patients. Moreover, it provides real-time data that shows trends in glucose measurements and help in maintaining a standard glucose level by controlling diabetes and complications associated with it. This will lead to the expansion of the global non-invasive glucose monitoring devices market at a CAGR of over 11% during the forecast period.
Integration of AI and RADAR technology in glucose monitoring
The integration of AI and RADAR systems in diagnostic devices has revolutionized the medical industry. This has led the researcher to develop non-invasive glucose monitoring devices combining AI and RADAR technologies, which enables people with diabetes to monitor their blood glucose levels. Vendors are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Such technologies will eliminate the need for finger pricking. The integration of data received from digital medical devices with mobile applications allow customers to easily monitor body parameters, such as changes in glucose levels. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global non-invasive glucose monitoring devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices manufacturers, that include Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.
Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Nemaura Medical Inc.
- RISE Life Science Corp.
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
Exhibit 01: Product Overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Wearable devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Wearable devices - Year-over-year growth 2019-2023 (%)
Exhibit 22: Non-wearable devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Non-wearable devices - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Abbott Laboratories - Vendor overview
Exhibit 45: Abbott Laboratories - Business segments
Exhibit 46: Abbott Laboratories - Organizational developments
Exhibit 47: Abbott Laboratories - Geographic focus
Exhibit 48: Abbott Laboratories - Segment focus
Exhibit 49: Abbott Laboratories - Key offerings
Exhibit 50: Abbott Laboratories - Key customers
Exhibit 51: Cnoga Medical Ltd. - Vendor overview
Exhibit 52: Cnoga Medical Ltd. - Key offerings
Exhibit 53: Cnoga Medical Ltd. - Key customers
Exhibit 54: Evia Medical Technologies - Vendor overview
Exhibit 55: Evia Medical Technologies - Business segments
Exhibit 56: Evia Medical Technologies - Key offerings
Exhibit 57: Evia Medical Technologies - Key customers
Exhibit 58: Helo Corp. - Vendor overview
Exhibit 59: Helo Corp. - Key offerings
Exhibit 60: Helo Corp. - Key customers
Exhibit 61: Integrity Applications Inc. - Vendor overview
Exhibit 62: Integrity Applications Inc. - Organizational developments
Exhibit 63: Integrity Applications Inc. - Geographic focus
Exhibit 64: Integrity Applications Inc. - Key offerings
Exhibit 65: Integrity Applications Inc. - Key customers
Exhibit 66: Nemaura Medical Inc. - Vendor overview
Exhibit 67: Nemaura Medical Inc. - Organizational developments
Exhibit 68: Nemaura Medical Inc. - Key offerings
Exhibit 69: Nemaura Medical Inc. - Key customers
Exhibit 70: RISE Life Science Corp. - Vendor overview
Exhibit 71: RISE Life Science Corp. - Business segments
Exhibit 72: RISE Life Science Corp. - Organizational developments
Exhibit 73: RISE Life Science Corp. - Key offerings
Exhibit 74: RISE Life Science Corp. - Key customers
Exhibit 75: Taiwan Biophotonic Co. - Vendor overview
Exhibit 76: Taiwan Biophotonic Co. - Organizational developments
Exhibit 77: Taiwan Biophotonic Co. - Key offerings
Exhibit 78: Taiwan Biophotonic Co. - Key customers
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Wearable devices - Market size and forecast 2018-2023
- Non-wearable devices - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Growing focus on collaborations for business expansion
- Integration of AI and RADAR technology in glucose monitoring
- Growing funding for non-invasive glucose monitoring technology
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Integrity Applications Inc.
- Nemaura Medical Inc.
- RISE Life Science Corp.
- Taiwan Biophotonic Co.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Product Overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Wearable devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Wearable devices - Year-over-year growth 2019-2023 (%)
Exhibit 22: Non-wearable devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Non-wearable devices - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Abbott Laboratories - Vendor overview
Exhibit 45: Abbott Laboratories - Business segments
Exhibit 46: Abbott Laboratories - Organizational developments
Exhibit 47: Abbott Laboratories - Geographic focus
Exhibit 48: Abbott Laboratories - Segment focus
Exhibit 49: Abbott Laboratories - Key offerings
Exhibit 50: Abbott Laboratories - Key customers
Exhibit 51: Cnoga Medical Ltd. - Vendor overview
Exhibit 52: Cnoga Medical Ltd. - Key offerings
Exhibit 53: Cnoga Medical Ltd. - Key customers
Exhibit 54: Evia Medical Technologies - Vendor overview
Exhibit 55: Evia Medical Technologies - Business segments
Exhibit 56: Evia Medical Technologies - Key offerings
Exhibit 57: Evia Medical Technologies - Key customers
Exhibit 58: Helo Corp. - Vendor overview
Exhibit 59: Helo Corp. - Key offerings
Exhibit 60: Helo Corp. - Key customers
Exhibit 61: Integrity Applications Inc. - Vendor overview
Exhibit 62: Integrity Applications Inc. - Organizational developments
Exhibit 63: Integrity Applications Inc. - Geographic focus
Exhibit 64: Integrity Applications Inc. - Key offerings
Exhibit 65: Integrity Applications Inc. - Key customers
Exhibit 66: Nemaura Medical Inc. - Vendor overview
Exhibit 67: Nemaura Medical Inc. - Organizational developments
Exhibit 68: Nemaura Medical Inc. - Key offerings
Exhibit 69: Nemaura Medical Inc. - Key customers
Exhibit 70: RISE Life Science Corp. - Vendor overview
Exhibit 71: RISE Life Science Corp. - Business segments
Exhibit 72: RISE Life Science Corp. - Organizational developments
Exhibit 73: RISE Life Science Corp. - Key offerings
Exhibit 74: RISE Life Science Corp. - Key customers
Exhibit 75: Taiwan Biophotonic Co. - Vendor overview
Exhibit 76: Taiwan Biophotonic Co. - Organizational developments
Exhibit 77: Taiwan Biophotonic Co. - Key offerings
Exhibit 78: Taiwan Biophotonic Co. - Key customers
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Nemaura Medical Inc.
- RISE Life Science Corp.
- MORE
The following companies are recognised as the key players in the global non-invasive glucose monitoring devices market: Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the integration of AI and RADAR technology in glucose monitoring.”
According to the report, one of the major drivers for this market is the increasing demand for non-invasive procedures.
Further, the report states that one of the major factors hindering the growth of this market is the high costs associated with non-invasive glucose monitoring devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the integration of AI and RADAR technology in glucose monitoring.”
According to the report, one of the major drivers for this market is the increasing demand for non-invasive procedures.
Further, the report states that one of the major factors hindering the growth of this market is the high costs associated with non-invasive glucose monitoring devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- Abbott Laboratories
- Cnoga Medical Ltd.
- Evia Medical Technologies
- Helo Corp.
- Integrity Applications Inc.
- Nemaura Medical Inc.
- RISE Life Science Corp.
- Taiwan Biophotonic Co.
Note: Product cover images may vary from those shown
LOADING...
